Combination of antioxidant substances for the treatment of alzheimer's disease
申请人:Colba R & D Inc.
公开号:US20030158237A1
公开(公告)日:2003-08-21
Disclosed is a pharmaceutical composition for the treatment of cognitive symptoms caused by Alzheimer's disease in a mammal. This composition comprising vitamin E, quercitin, caffeic acid, nicotinic acid or derivatives and/or analog thereof, and a pharmaceutically acceptable excipient.